Vimal Mehta

BTAI

Vimal Mehta serves as director, officer: CEO and President at BioXcel Therapeutics, Inc. (BTAI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

11 trades

$18.86M

Net Position

Net Seller

$18.86M

Companies Traded

BTAI

Active Period

Jun 2021 – May 2026

11 total trades

Most Recent

Sell BTAI

May 22, 2026 · $21.1K

Vimal Mehta's Insider Trading at BioXcel Therapeutics, Inc. (BTAI)

Buys

0 · $0.00

Sells

11 · $18.86M

Total Shares Bought

Total Shares Sold

948,198

BTAI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 22, 2026	Sell	19,419	$1.09	$21.1K	69,598
Dec 14, 2024	Sell	3,117	$0.36	$1.1K	0
Sep 14, 2024	Sell	1,982	$0.69	$1.4K	0
Jun 14, 2024	Sell	2,134	$1.28	$2.7K	0
Jun 4, 2024	Sell	252,028	$1.61	$405.1K	0
Mar 14, 2024	Sell	5,268	$2.62	$13.8K	0
Jun 14, 2023	Sell	60,000	$20.86	$1.25M	0
May 22, 2023	Sell	6,500	$25.79	$167.6K	0
Mar 20, 2023	Sell	64,500	$18.97	$1.22M	0
Dec 15, 2022	Sell	60,000	$19.69	$1.18M	0
Jun 25, 2021	Sell	473,250	$30.83	$14.59M	0

Related Insiders

Javier Rodriguez

officer: See Remarks

BTAISell · May 22, 2026

Richard I Steinhart

officer: Chief Financial Officer

BTAISell · May 22, 2026

Frank Yocca

officer: Chief Scientific Officer

BTAISell · May 22, 2026

Explore More Insider Trading Data

BTAI Insider Trading Activity

View all insider trades at BioXcel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity